GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Boewe Systec AG (STU:BSY) » Definitions » Shares Outstanding (Diluted Average)

Boewe Systec AG (STU:BSY) Shares Outstanding (Diluted Average) : 6.6 Mil (As of Dec. 2008)


View and export this data going back to . Start your Free Trial

What is Boewe Systec AG Shares Outstanding (Diluted Average)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Boewe Systec AG's average diluted shares outstanding for the quarter that ended in Dec. 2008 was 6.6 Mil.


Boewe Systec AG Shares Outstanding (Diluted Average) Historical Data

The historical data trend for Boewe Systec AG's Shares Outstanding (Diluted Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boewe Systec AG Shares Outstanding (Diluted Average) Chart

Boewe Systec AG Annual Data
Trend Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Shares Outstanding (Diluted Average)
Get a 7-Day Free Trial 6.59 6.60 6.60 6.60 6.60

Boewe Systec AG Semi-Annual Data
Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08
Shares Outstanding (Diluted Average) Get a 7-Day Free Trial 6.59 6.60 6.60 6.60 6.60

Boewe Systec AG Shares Outstanding (Diluted Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Boewe Systec AG  (STU:BSY) Shares Outstanding (Diluted Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Boewe Systec AG Shares Outstanding (Diluted Average) Related Terms

Thank you for viewing the detailed overview of Boewe Systec AG's Shares Outstanding (Diluted Average) provided by GuruFocus.com. Please click on the following links to see related term pages.


Boewe Systec AG (STU:BSY) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Werner-von-Siemens-Street 1, Augsburg, DEU, 86159
Boewe Systec AG is a solutions provider for printing and mail processing centres. The company manufactures and markets inserting systems. It also offers card mailing systems, letter and flats sorting, intralogistics and reading technologies in the field of document processing. It provides services to classic transactional or direct mail applications, modern mail processing centers, intralogistics or serialization in the pharmaceutical industry.